Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death-论文-万方医学网

首页> > Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death

Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death

导出原文传递

翻译打印收藏纠错

第一作者： Sara,Hedlund M?ller

作者： Sara,Hedlund M?ller ^[1] ; Dea,Haagensen Kofod ^[2] ; Morten,Schou ^[3] ; Christian,Torp-Pedersen ^[4] ; Gunnar,Gislason ^[5] ; Nicholas,Carlson ; Morten,Lindhardt

作者单位： Department of internal medicine, Copenhagen University Hospital Holbaek, Holbaek ^[1] Department of cardiology, Herlev Hospital, University Copenhagen ^[2] Department of Cardiology, Nordsjaelland Hospital ^[3] Department of cardiology, Copenhagen University Hospital Gentofte ^[4] Department of Nephrology, Copenhagen University Hospital Rigshospitalet ^[5]

发布时间 2024-04-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death

相似文献

同项目论文

相关期刊

检索历史 清除

Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death

相似文献

同项目论文

相关期刊

检索历史清除